Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma

Fig. 5

Association between KIF23 V1 or KIF23 V2 protein expression and overall survival (OS) of HCC patients. Correlation of KIF23 V1 expression with 3-year (a) or 5-year (b) OS of HCC patients. Correlation of KIF23 V2 expression with 3-year (c) or 5-year (d) OS of HCC patients. The group with expression of KIF23 V1 showed significantly better survival than the group without expression of KIF23 V1 (pā€‰=ā€‰0.0052). Patients were categorized by the median H-scores of KIF23 V2 (60) or by KIF23 V1 expression or not

Back to article page